<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00418743</url>
  </required_header>
  <id_info>
    <org_study_id>GFPC 05-01</org_study_id>
    <nct_id>NCT00418743</nct_id>
  </id_info>
  <brief_title>Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)</brief_title>
  <official_title>A Phase II Randomised Trial of Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC), Comparing Oral Combination Chemotherapy (CCNU, Cyclophosphamide, Etoposide) With Intravenous Association Chemotherapy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Francais De Pneumo-Cancerologie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Amgen</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupe Francais De Pneumo-Cancerologie</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine treatment efficacy and tolerability of second-line
      treatment in patients with small cell lung cancer comparing oral combinaison chemotherapy
      with intravenous combination chemotherapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Determined treatment efficacy and tolerability of second-line treatment in patients with
      small cell lung cancer comparing oral combinaison chemotherapy with intravenous combination
      chemotherapy.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2005</start_date>
  <completion_date type="Anticipated">May 2010</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">138</enrollment>
  <condition>Small Cell Lung Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Small-cell lung cancer who, after (at least) a first line of chemotherapy
        based on platinum, had a partial response and then progressed, or who had a complete
        response and then relapsed within three months following the last course of this first-line
        therapy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Small-cell lung cancer.

          -  Patients who, after (at least) a first line of chemotherapy based on platinum, had a
             partial response and then progressed, or who had a complete response and then relapsed
             within three months following the last course of this first-line therapy.

          -  Measurable or assessable disease.

          -  Life expectancy &gt;2 months.

          -  Patients with a therapeutic risk level of &lt;5 points (see section 6: &quot;Treatment
             flowchart&quot;).

          -  Age &gt;18 years;

          -  Performance status (WHO) &lt;2;

          -  One measurable target lesion in a non irradiated region;

          -  Prior radiotherapy authorized unless it targeted the only measurable lesion;

          -  Biological criteria: WBC &gt;2000/mm3, PMN &gt;1500/mm3, platelets &gt;100 000/mm3, creatinemia
             &lt;2 x ULN, bilirubinemia &lt;ULN, ALT and AST &lt;2.5 x ULN (&lt; 5 N if liver metastases)

          -  normal ECG

          -  written informed consent.

        Exclusion Criteria:

          -  Non small-cell lung cancer.

          -  No objective response to platinum-based therapy

          -  Complete response lasting more than three months after the last course of first-line
             treatment.

          -  Symptomatic brain metastases.

          -  Bone metastases, carcinomatous lymphangitis, ascites or pleurisy as sole assessable
             disease manifestations.- Concurrent participation in another clinical trial.

          -  Therapeutic risk level of 6 points or more (see table)

          -  Uncontrolled clotting disorders;

          -  Uncontrolled severe infection;

          -  History of another malignancy, except for cervical carcinoma in situ or basocellular
             cancer that are considered cured;

          -  Psychological, familial, sociological or geographic circumstances preventing treatment
             follow-up as defined in the protocol;

          -  Patients deprived of their rights for administrative or legal reasons.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christos CHOUAID, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Francais De Pneumo-Cancerologie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christos CHOUAID, Professor</last_name>
    <phone>+33 1 49 28 25 16</phone>
    <email>christos.chouid@sat.ap-hop-paris.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Angers</city>
        <zip>49033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry URBAN, Doctor</last_name>
      <phone>+33241355844</phone>
      <email>thurban@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Thierry URBAN, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie BAIZE, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thierry JEANFAIVRE, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José HUREAUX, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 05</name>
      <address>
        <city>Bastia</city>
        <zip>20200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Cl MOURIES, Doctor</last_name>
      <phone>+33495591080</phone>
      <email>jcmouries@ch-bastia.fr</email>
    </contact>
    <investigator>
      <last_name>Jean Cl MOURIES, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 22</name>
      <address>
        <city>Beauvais</city>
        <zip>60021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric BOUCHAERT, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Eric BOUCHAERT, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Morvan</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles ROBINET, Doctor</last_name>
      <phone>+33298223428</phone>
      <email>gilles.robinet@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Gilles ROBINET, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre François Baclesse</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Radj GERVAIS, Doctor</last_name>
      <phone>+33231455013</phone>
      <email>r.gervais@baclesse.fr</email>
    </contact>
    <investigator>
      <last_name>Radj GERVAIS, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 43</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Radj GERVAIS, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Radj GERVAIS, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier René Dubos</name>
      <address>
        <city>Cergy-pontoise</city>
        <zip>95301</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gislaine FRABOULET, Doctor</last_name>
      <phone>+33130754282</phone>
      <email>gislaine.fraboulet@ch-pontoise.fr</email>
    </contact>
    <investigator>
      <last_name>Gislaine FRABOULET, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 33</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle MONNET, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Isabelle MONNET, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 07</name>
      <address>
        <city>Draguignan</city>
        <zip>83300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé LECAER, Doctor</last_name>
      <phone>+33 4 94 60 51 12</phone>
      <email>herve.lecaer@ch-draguignan.fr</email>
    </contact>
    <investigator>
      <last_name>Hervé LE CAER, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 32</name>
      <address>
        <city>Elbeuf</city>
        <zip>76503</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe DAVID</last_name>
    </contact>
    <investigator>
      <last_name>Philippe DAVID, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 04</name>
      <address>
        <city>GAP</city>
        <zip>05000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal THOMAS, Doctor</last_name>
      <phone>+33 4 92 40 61 26</phone>
      <email>pascal.thomas@chicas-gap.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal THOMAS, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Les Oudairies</name>
      <address>
        <city>La Roche Sur Yon</city>
        <zip>85000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Acya BIZIEUX-TAMINY, Doctor</last_name>
      <phone>+33251446164</phone>
      <email>acya.bizieux@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Acya BIZIEUX-TAMINY, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie MARCQ, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital du Cluzeau</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain VERGNENEGRE, Professor</last_name>
      <phone>+33 5 55 05 66 29</phone>
      <email>avergne@unilim.fr</email>
    </contact>
    <investigator>
      <last_name>Alain VERGNENEGRE, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional</name>
      <address>
        <city>Longjumeau</city>
        <zip>91160</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gérard OLIVIERO, Doctor</last_name>
      <phone>+33164543181</phone>
      <email>gerard.oliviero@ch-longjumeau.fr</email>
    </contact>
    <investigator>
      <last_name>Gérard OLIVIERO, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal ASSOULINE, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Lyon</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence GERINIERE, Doctor</last_name>
      <phone>+33478861328</phone>
      <email>lairence.geriniere@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Laurence GERINIERE, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre J SOUQUET, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 25</name>
      <address>
        <city>Mantes La Jolie</city>
        <zip>78200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean B AULIAC, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Jean Be AULIAC, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 06</name>
      <address>
        <city>Marseille</city>
        <zip>13274</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice BARLESI, Doctor</last_name>
      <phone>+33 4 91 74 47 36</phone>
      <email>fabrice.barlesi@aphm.fr</email>
    </contact>
    <investigator>
      <last_name>Fabrice BARLESI, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurent GREILLIER, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe ASTOUL, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 27</name>
      <address>
        <city>Martigues</city>
        <zip>13695</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé JULLIAN, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Hervé JULLIAN, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 01</name>
      <address>
        <city>Meaux</city>
        <zip>77108</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francois BLANCHON, Doctor</last_name>
      <phone>+33 1 64 35 38 56</phone>
      <email>f-blanchon@ch-meaux.fr</email>
    </contact>
    <investigator>
      <last_name>Francois BLANCHON, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christos CHOUAID, Professor</last_name>
      <phone>+33 1 48 28 25 16</phone>
      <email>christos.chouaid@sat.ap-hop-paris.fr</email>
    </contact>
    <investigator>
      <last_name>Christos CHOUAID, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 17</name>
      <address>
        <city>Rouen</city>
        <zip>76233</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique PAILLOTIN, DOCTOR</last_name>
    </contact>
    <investigator>
      <last_name>Dominique PAILLOTIN, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Yves Le Foll</name>
      <address>
        <city>Saint Brieuc</city>
        <zip>22023</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gwenaelle LE GARFF, Doctor</last_name>
      <phone>+33296017123</phone>
      <email>gwenaelle.legarff@ch-stbrieuc.fr</email>
    </contact>
    <investigator>
      <last_name>Gwenaelle LE GARFF, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 14</name>
      <address>
        <city>Toulon</city>
        <zip>83800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henri BERARD, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Henri BERARD, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 11</name>
      <address>
        <city>Villefranche Sur Saone</city>
        <zip>69655</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lionel FALCHERO, Doctor</last_name>
      <phone>+33 4 74 09 27 23</phone>
    </contact>
    <investigator>
      <last_name>Lionel FALCHERO, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.g-f-p-c.org</url>
    <description>Groupement Francais de Pneumo-cancérologie</description>
  </link>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2007</study_first_submitted>
  <study_first_submitted_qc>January 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2007</study_first_posted>
  <last_update_submitted>March 8, 2010</last_update_submitted>
  <last_update_submitted_qc>March 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Pr CHOUAID</name_title>
    <organization>GFPC</organization>
  </responsible_party>
  <keyword>cancer</keyword>
  <keyword>Lung cancer</keyword>
  <keyword>small-cell lung cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Small Cell Lung Carcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

